Potassium Ion

Potassium Ion

SCHEMBL9688

CC([O-])=S.[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL28403449 0.91
Potassium Ion SCHEMBL10631852 0.91
SCHEMBL10366909 0.89
SCHEMBL4948681 0.89
SCHEMBL7008604 0.89
SCHEMBL9156588 0.89 CA1 (0.42)
SCHEMBL48308 0.89
SCHEMBL4947312 0.89
SCHEMBL22070012 0.89
SCHEMBL4843117 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8308 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079228-A Preparation process of electronic grade antimonous oxide 2026-05-26 CN claimed
WO-2025244956-A1 METHODS OF MANUFACTURING DANICAMTIV MyoKardia, Inc. (US) 2025-11-27 WO claimed
CN-113861257-B Dehalogenation method and application of 9-halogenated steroid compound 天津药业研究院股份有限公司 2025-06-17 CN claimed
CN-120136886-A PDE4 inhibitor with pyranonaphthyridone skeleton and preparation method and application thereof 中山大学 2025-06-13 CN claimed
CN-120024112-A Composite fabric with electromagnetic shielding effect, preparation method and application 扬州斯帕克实业有限公司 2025-05-23 CN claimed
CN-119931467-A UV-LED cured spraying agent for furniture and preparation method thereof 广州汉光科技有限公司 2025-05-06 CN claimed
CN-119775172-A Compound and synthesis method thereof 浦拉司科技(上海)有限责任公司 2025-04-08 CN claimed
CN-119707943-A Organic fluorescent dye and preparation method and application thereof 长三角物理研究中心有限公司 2025-03-28 CN claimed
CN-119684174-A Preparation method of dithiothreitol 苏州昊帆生物股份有限公司 2025-03-25 CN claimed
CN-119591617-A Novel disulfide diphenol ether compound and preparation method and application thereof 中南大学湘雅医院 2025-03-11 CN claimed
EP-0759437-A1 PROCESSES FOR THE PRODUCTION OF 2-ISOCEPHEM DERIVATIVES OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-02-26 EP claimed
US-5534651-A REACTING A BUTYROLACTONE WITH THIOCARBOXYLATE TO FORM THIOLACTONE; DECYCLIZATION WITH NUCLEOPHILE LONZA LTD. (CH) 1996-07-09 US claimed
EP-0671917-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES ONCOMEMBRANE, INC. (US) 1995-09-20 EP claimed
WO-1993019760-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES THE BIOMEMBRANE INSTITUTE (US) 1993-10-14 WO claimed
EP-0457250-A2 Novel bifunctional linking compounds, conjugates and methods for their production BRISTOL-MYERS SQUIBB COMPANY (US) 1991-11-21 EP claimed
EP-0229007-A1 Anticonvulsant gamma-thiobutyrolactone derivatives WASHINGTON UNIVERSITY (US) 1987-07-15 EP claimed
US-4661294-A Biologically active 1-thio derivatives of vitamin D THE GENERAL HOSPITAL CORPORATION (US) 1987-04-28 US claimed
EP-0100104-B1 MURAMYLDIPEPTIDE DERIVATIVES DAIICHI SEIYAKU CO., LTD. (JP) 1986-01-29 EP claimed
EP-0100104-A1 Muramyldipeptide derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1984-02-08 EP claimed
US-4413120-A FROM L-RHAMNAL, MULTISTAGE, ANTHRACYCLINE ANTIBIOTIC INTERMEDIATES PURDUE RESEARCH FOUNDATION (US) 1983-11-01 US claimed